BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 37215218)

  • 1. Iron metabolism and ferroptosis in diabetic bone loss: from mechanism to therapy.
    Bao J; Yan Y; Zuo D; Zhuo Z; Sun T; Lin H; Han Z; Zhao Z; Yu H
    Front Nutr; 2023; 10():1178573. PubMed ID: 37215218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of osteoblast ferroptosis via the METTL3/ASK1-p38 signaling pathway in high glucose and high fat (HGHF)-induced diabetic bone loss.
    Lin Y; Shen X; Ke Y; Lan C; Chen X; Liang B; Zhang Y; Yan S
    FASEB J; 2022 Mar; 36(3):e22147. PubMed ID: 35104016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetic mellitus related osteoporosis: focusing on ferroptosis.
    Chen Y; Zhao W; Hu A; Lin S; Chen P; Yang B; Fan Z; Qi J; Zhang W; Gao H; Yu X; Chen H; Chen L; Wang H
    J Transl Med; 2024 Apr; 22(1):409. PubMed ID: 38693581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis - A new target of osteoporosis.
    Gao Z; Chen Z; Xiong Z; Liu X
    Exp Gerontol; 2022 Aug; 165():111836. PubMed ID: 35598699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis: Mechanisms and role in diabetes mellitus and its complications.
    Liu P; Zhang Z; Cai Y; Li Z; Zhou Q; Chen Q
    Ageing Res Rev; 2024 Feb; 94():102201. PubMed ID: 38242213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Anti-Osteoporosis Mechanism of VK2: Interfering with Ferroptosis via AMPK/SIRT1 Pathway in Type 2 Diabetic Osteoporosis.
    Jin C; Tan K; Yao Z; Lin BH; Zhang DP; Chen WK; Mao SM; Zhang W; Chen L; Lin Z; Weng SJ; Bai BL; Zheng WH; Zheng G; Wu ZY; Yang L
    J Agric Food Chem; 2023 Feb; 71(6):2745-2761. PubMed ID: 36719855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Ferritin Deficiency Promotes Osteoblastic Ferroptosis Via Mitophagy in Type 2 Diabetic Osteoporosis.
    Wang X; Ma H; Sun J; Zheng T; Zhao P; Li H; Yang M
    Biol Trace Elem Res; 2022 Jan; 200(1):298-307. PubMed ID: 33594527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATF3 Regulates Osteogenic Function by Mediating Osteoblast Ferroptosis in Type 2 Diabetic Osteoporosis.
    Zhao Y; Du Y; Gao Y; Xu Z; Zhao D; Yang M
    Dis Markers; 2022; 2022():9872243. PubMed ID: 36340581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis: A New Regulatory Mechanism in Osteoporosis.
    Liu P; Wang W; Li Z; Li Y; Yu X; Tu J; Zhang Z
    Oxid Med Cell Longev; 2022; 2022():2634431. PubMed ID: 35082963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research progress on ferroptosis in diabetic kidney disease.
    Wu Y; Chen Y
    Front Endocrinol (Lausanne); 2022; 13():945976. PubMed ID: 36246888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities.
    Miao R; Fang X; Zhang Y; Wei J; Zhang Y; Tian J
    Cell Death Dis; 2023 Mar; 14(3):186. PubMed ID: 36882414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maresin1 Suppresses High-Glucose-Induced Ferroptosis in Osteoblasts via NRF2 Activation in Type 2 Diabetic Osteoporosis.
    Zhang Z; Ji C; Wang YN; Liu S; Wang M; Xu X; Zhang D
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporotic bone loss from excess iron accumulation is driven by NOX4-triggered ferroptosis in osteoblasts.
    Zhang H; Wang A; Li G; Zhai Q; Huang Z; Wang X; Cao Z; Liu L; Liu G; Chen B; Zhu K; Xu Y; Xu Y
    Free Radic Biol Med; 2023 Mar; 198():123-136. PubMed ID: 36738798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus a risk for osteoporosis?
    Leidig-Bruckner G; Ziegler R
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S493-514. PubMed ID: 11460594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting ferroptosis suppresses osteocyte glucolipotoxicity and alleviates diabetic osteoporosis.
    Yang Y; Lin Y; Wang M; Yuan K; Wang Q; Mu P; Du J; Yu Z; Yang S; Huang K; Wang Y; Li H; Tang T
    Bone Res; 2022 Mar; 10(1):26. PubMed ID: 35260560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis is involved in corpus cavernosum smooth muscle cells impairment in diabetes mellitus-induced erectile dysfunction.
    Xu W; Sun T; Wang J; Wang T; Wang S; Liu J; Liu K; Li H
    Andrology; 2023 Feb; 11(2):332-343. PubMed ID: 36098277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of Ferroptosis and Its Role in Type 2 Diabetes Mellitus.
    Sha W; Hu F; Xi Y; Chu Y; Bu S
    J Diabetes Res; 2021; 2021():9999612. PubMed ID: 34258295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications.
    Yang XD; Yang YY
    Front Endocrinol (Lausanne); 2022; 13():853822. PubMed ID: 35422764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.